| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 84.94B | 85.16B | 87.43B | 77.10B | 64.73B | 53.55B |
| Gross Profit | 32.51B | 32.94B | 35.67B | 29.74B | 21.62B | 17.61B |
| EBITDA | 12.89B | 13.78B | 18.27B | 14.24B | 8.98B | 5.99B |
| Net Income | 7.17B | 7.63B | 11.38B | 9.43B | 4.77B | 2.79B |
Balance Sheet | ||||||
| Total Assets | 102.35B | 105.77B | 101.37B | 86.26B | 74.92B | 67.73B |
| Cash, Cash Equivalents and Short-Term Investments | 21.69B | 24.06B | 18.76B | 13.93B | 14.31B | 10.40B |
| Total Debt | 5.45B | 5.97B | 4.26B | 2.25B | 2.81B | 3.83B |
| Total Liabilities | 25.72B | 27.51B | 29.70B | 25.08B | 23.09B | 20.62B |
| Stockholders Equity | 76.00B | 77.64B | 70.95B | 60.61B | 51.36B | 46.67B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.93B | 4.91B | 991.00M | 5.47B | 1.18B |
| Operating Cash Flow | 0.00 | 11.34B | 9.70B | 5.84B | 7.17B | 3.42B |
| Investing Cash Flow | 0.00 | -5.44B | -4.65B | -4.84B | -1.66B | -2.07B |
| Financing Cash Flow | 0.00 | -1.29B | -546.00M | -1.87B | -2.06B | -1.15B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥36.62B | 7.75 | ― | 3.59% | 6.91% | 13.17% | |
76 Outperform | ¥16.09B | 7.85 | ― | 2.81% | 0.23% | -8.64% | |
75 Outperform | ¥17.61B | 7.05 | ― | 3.09% | 0.27% | 7.57% | |
68 Neutral | ¥101.31B | 25.05 | ― | 2.17% | -2.39% | -29.17% | |
66 Neutral | ¥104.70B | 13.03 | ― | 3.53% | -0.58% | -46.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥66.53B | 12.73 | ― | 3.27% | 12.09% | 5.46% |